Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pharnext SA

ALPHA
Current price
0.0002 EUR +0.000000000037 EUR (+0.00%)
Last closed 0.0002 EUR
ISIN FR001400BV89
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 2 667 EUR
Yield for 12 month -100.00 %
1Y
3Y
5Y
10Y
15Y
ALPHA
21.11.2021 - 28.11.2021

Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France. Address: 14 rue de la REpublique, Suresnes, France, 92150

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11 604.91 EUR

P/E ratio

Dividend Yield

101203.43 %

Current Year

+10 097 EUR

Last Year

+564 EUR

Current Quarter

-596 832 EUR

Last Quarter

+151 458 EUR

Current Year

-19 526 800 EUR

Last Year

+2 279 853 EUR

Current Quarter

-20 133 729 EUR

Last Quarter

+770 441 EUR

Key Figures ALPHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 535 135 EUR
Operating Margin TTM 2058.26 %
PE Ratio
Return On Assets TTM -277.44 %
PEG Ratio
Return On Equity TTM -1348.44 %
Wall Street Target Price 11 604.91 EUR
Revenue TTM 173 609 EUR
Book Value -0.25 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -36.5 %
Dividend Yield 101203.43 %
Gross Profit TTM 3 599 398 EUR
Earnings per share -201.94 EUR
Diluted Eps TTM -201.94 EUR
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALPHA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALPHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 35.78 %
Last Split Factor 1:10000
Payout Ratio
Last Split Date 15.02.2024
Dividend Date

Stock Valuation ALPHA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2615.7727
Price Sales TTM 0.0154
Enterprise Value EBITDA -0.6022
Price Book MRQ 24.5429

Financials ALPHA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALPHA

For 52 weeks

0.0001 EUR 147.64 EUR
50 Day MA 0.0002 EUR
Shares Short Prior Month
200 Day MA 0.2 EUR
Short Ratio
Shares Short
Short Percent